Lithuania Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Creating iOS Games: Beginner Course Marin Todorov teaches you how to create an iPhone game easily and simply using Cocos2d in this $99 online course. From our sponsors

Lithuania Pharmaceuticals and Healthcare Report Q4 2013 Oct 23rd 2013, 00:00, by swapnil View: We will retain our cautious view of the Lithuanian pharmaceutical market for the remainder of the year. Given that out-of-pocket payments represent a substantial proportion of total drug expenditure – and also that the government remains committed to deficit reduction – we expect low single-digit growth in the country’s pharmaceutical market values. Inflation has also been trending lower, partly due to weakness in the underlying consumer demand. Headline Expenditure Projections ? Pharmaceuticals: LTL1.72bn (US$640mn) in 2012 to LTL1.73bn (US$668mn) in 2013; +0.9% in local currency terms and +4.5% in US dollar terms. Forecast unchanged in relation to previous quarter. Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=122233. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/lithuania-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions